Literature DB >> 2890576

Association of membranous nephropathy with T-cell receptor constant beta chain and immunoglobulin heavy chain switch region polymorphisms.

A G Demaine1, R W Vaughan, D H Taube, K I Welsh.   

Abstract

We have investigated T-cell antigen receptor constant beta chain genes (Tcr C beta) and immunoglobulin (Ig) heavy chain switch region genes of HLA-DR-typed patients with membranous nephropathy (MN) employing DNA restriction fragment length polymorphism (RFLP) analysis. When a Tcr C beta probe in conjunction with the restriction endonuclease Bgl II was used, a significant increase in the frequency of a 10.0; 9.2 kb heterozygous RFLP phenotype was found in MN (75.0% versus 42.1% in controls; P = 0.002). When Sst I-restricted DNA from MN patients was hybridized with a DNA probe homologous to the switch region flanking the Ig C mu heavy chain gene (S mu), there was a significant decrease in the frequency of the 2.1; 2.6 kb heterozygous RFLP phenotype in MN (24.0% versus 54.6% in controls; P = 0.004). These results suggest that Tcr beta and Ig heavy chain loci, as well as HLA antigens, may be important in the pathogenesis of MN.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2890576     DOI: 10.1007/bf00404439

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  20 in total

1.  On estimating the relation between blood group and disease.

Authors:  B WOOLF
Journal:  Ann Hum Genet       Date:  1955-06       Impact factor: 1.670

2.  A T cell receptor V beta segment that imparts reactivity to a class II major histocompatibility complex product.

Authors:  J W Kappler; T Wade; J White; E Kushnir; M Blackman; J Bill; N Roehm; P Marrack
Journal:  Cell       Date:  1987-04-24       Impact factor: 41.582

3.  Cell-type specificity of immunoglobulin gene expression is regulated by at least three DNA sequence elements.

Authors:  R Grosschedl; D Baltimore
Journal:  Cell       Date:  1985-07       Impact factor: 41.582

4.  Relation of mesangial IgA glomerulonephritis to polymorphism of immunoglobulin heavy chain switch region.

Authors:  A G Demaine; M Rambausek; J F Knight; D G Williams; K I Welsh; E Ritz
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

5.  "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1984-02       Impact factor: 3.365

6.  Segregation of polymorphic T-cell receptor genes in human families.

Authors:  M A Robinson; T J Kindt
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

7.  Immunoglobulin (Gm) allotype frequencies in idiopathic membranous nephropathy and minimal change nephropathy.

Authors:  A G Demaine; J S Cameron; D T Taube; R W Vaughan; K I Welsh
Journal:  Transplantation       Date:  1984-05       Impact factor: 4.939

8.  Immunoglobulin heavy chain switch region restriction fragment length polymorphisms are associated with renal disease.

Authors:  A G Demaine; D H Taube; R W Vaughan; L A Kerr; K I Welsh
Journal:  Clin Exp Immunol       Date:  1986-11       Impact factor: 4.330

9.  A human T cell-specific cDNA clone encodes a protein having extensive homology to immunoglobulin chains.

Authors:  Y Yanagi; Y Yoshikai; K Leggett; S P Clark; I Aleksander; T W Mak
Journal:  Nature       Date:  1984 Mar 8-14       Impact factor: 49.962

10.  Multiple DNA fragment polymorphisms associated with immunoglobulin mu chain switch-like regions in man.

Authors:  N Migone; J Feder; H Cann; B van West; J Hwang; N Takahashi; T Honjo; A Piazza; L L Cavalli-Sforza
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

View more
  9 in total

1.  Haplotyping the human T-cell receptor beta-chain gene complex by use of restriction fragment length polymorphisms.

Authors:  P Charmley; A Chao; P Concannon; L Hood; R A Gatti
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

2.  Relation of mesangial IgA glomerulonephritis to polymorphism of immunoglobulin heavy chain switch region.

Authors:  A G Demaine; M Rambausek; J F Knight; D G Williams; K I Welsh; E Ritz
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

Review 3.  Immunogenetics of glomerulonephritis.

Authors:  G A Müller; C A Müller
Journal:  Clin Investig       Date:  1993-10

4.  Thyroglobulin antibodies in Graves' disease are associated with T-cell receptor beta chain and major histocompatibility complex loci.

Authors:  A G Demaine; S Ratanachaiyavong; R Pope; D Ewins; B A Millward; A M McGregor
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

5.  Ongoing immunoglobulin class switch DNA recombination in lupus B cells: analysis of switch regulatory regions.

Authors:  Paolo Casali; Mary K Crow; Shiquan Liu; Andrea Cerutti
Journal:  Autoimmunity       Date:  2004 Sep-Nov       Impact factor: 2.815

6.  A T cell receptor beta chain variable region polymorphism associated with radiographic progression in rheumatoid arthritis.

Authors:  N de Vries; C F Prinsen; E B Mensink; P L van Riel; M A van't Hof; L B van de Putte
Journal:  Ann Rheum Dis       Date:  1993-05       Impact factor: 19.103

7.  An abnormal T cell repertoire in hypergammaglobulinaemic primary Sjögren's syndrome.

Authors:  R A Kay; E M Hay; P A Dyer; C Dennett; L M Green; R M Bernstein; P J Holt; R S Pumphrey; A W Boylston; W E Ollier
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

8.  Association between a T cell receptor restriction fragment length polymorphism and systemic lupus erythematosus.

Authors:  J G Tebib; J Alcocer-Varela; D Alarcon-Segovia; P H Schur
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

9.  Lack of association of T cell receptor beta-chain constant region polymorphism with insulin-dependent diabetes mellitus in Finland.

Authors:  H Reijonen; S Silvennoinen-Kassinen; J Ilonen; M Knip
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.